Related Experiment Videos
Enhanced p73 expression during differentiation and complex p73 isoforms in myeloid leukemia
M P Tschan1, T J Grob, U R Peters
1Department of Clinical Research, Institute of Medical Oncology, Bern, Switzerland.
Biochemical and Biophysical Research Communications
|October 12, 2000
Summary
The p73 gene, a p53 homologue, shows altered expression in myeloid leukemias. Specific shorter p73 isoforms, including epsilon, are elevated in leukemia cells, suggesting p73's role in myeloid development and cancer.
Area of Science:
- Molecular Biology
- Cancer Biology
- Hematology
Background:
- The p53 homologue p73 exists in multiple isoforms.
- Unlike p53, p73 mutations are rare in cancers, but altered expression is observed.
- The role of p73 in myeloid cell development and leukemia is not fully understood.
Purpose of the Study:
- To investigate the expression patterns of p73 isoforms in normal and malignant myeloid cells.
- To determine if p73 is involved in normal myeloid differentiation.
- To assess the involvement of p73 in the development of myeloid leukemias.
Main Methods:
- Analysis of p73 isoform expression in progenitor and mature normal myeloid cells.
- Investigation of p73 isoform expression in cells from acute and chronic myeloid leukemias.
- Comparison of p73 isoform expression profiles between normal and leukemic myeloid cells.
Main Results:
- p73 expression is significantly upregulated during the differentiation of myeloid leukemic cells.
- Leukemic blasts exhibit increased expression of shorter p73 isoforms (gamma, delta, epsilon, zeta).
- The epsilon p73 isoform is uniquely expressed in leukemic cells and absent in mature normal myeloid cells.
Conclusions:
- p73 plays a role in myeloid differentiation.
- Altered expression of p73 isoforms is associated with leukemic degeneration.
- Specific p73 isoforms may serve as biomarkers for myeloid leukemia.